Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
diagnostics
China’s Burning Rock Biotech completes Series C financing of RMB 850 million
By
Dean Koh
|
05:30 am |
February 14, 2019
Burning Rock Biotech, which was founded in 2014 and focuses on NGS (Next-Generation Sequencing) diagnostics solutions for precision medicine in oncology, today announced the closing of the Series C financing totaling RMB 850 million.
Microskia: Another mobile phone microscope
By
Brian Dolan
|
06:18 am |
November 09, 2009
First page
« First
Previous page
‹‹
Page
1
Page
2
Current page
3